Answer:
Back pain is a common problem among adults in the U.S., with nearly 40% of people reporting general back pain and 8% reporting chronic back pain (National Council on Aging, 5-13/2025; CDC, 7/2021). The incidence is even higher among older adults, affecting 46% of people 65 and older (National Council on Aging, 5-13/2025). Potential strategies for managing back pain include improving sleep habits, staying active, maintaining a healthy weight, physical therapy, and use of over-the-counter or prescribed anti-inflammatory or pain-relief medications (such as NSAIDs) (National Council on Aging, 5-13/2025).
Some people may also consider using supplements to help reduce back pain. There is limited evidence that certain supplements may provide modest benefit. Meanwhile, some others don't seem to work, and some that are promoted for back pain relief have not been evaluated for this use in clinical studies.
Sign in as a member to learn which of the following supplements may help and which might not: Alpha-lipoic acid, cannabidiol (CBD), chuchuhuasi, collagen, devil’s claw, fish oil, glucosamine, palmitoylethanolamide (PEA), pregnenolone, proteolytic enzymes, turmeric, vitamin D, and white willow bark.
Also see our article about topical menthol creams, such as Biofreeze, for pain relief.
+
โ 27 sources
In addition the results of its expert testing, ConsumerLab uses only high-quality,
evidence based, information sources. These sources include peer-reviewed studies
and information from agencies such as the FDA and USDA, and the National Academy of Medicine.
On evolving topics, studies from pre-print journals may be sourced.
All of our content is reviewed by medical doctors and doctoral-level experts in pharmacology,
toxicology, and chemistry. We continually update and medically review our information to
keep our content trustworthy, accurate, and reliable.
The following sources are referenced in this article:
- Bebee, Med J Aust 2021
- Brady, J Ster Biochem Mol Biol 2018
- CDC, 7/2021
- Cassanego, Pharmacol Res 2022
- Chrubasik, Am J Med 2000
- Clayton, Int J Mol Sci 2021
- Cruccu, CNS Neurol Disord Drug Targets 2019
- Cuspidi, J Clin Hypertens (Greenwich
- Farpour, Evid Based Complement Alternat Med 2021
- Gupta, J Back Musculoskelet Rehabil 2025
- Inaba, J Nat Med 2010
- Kare, Pharmacognosy Mag 2025
- Lin, Curr Opin Endocr Metab Res 2022
- Majumdar, Explore (NY
- Malanik, Molecules 2019
- Maroon, Surg Neurol 2006
- National Council on Aging, 5-13/2025
- Naylor, JAMA Netw Open 2020
- Oltean, Cochrane Database Syst Rev 2014
- Ranieri, Int J Immunopathol Pharmacol 2009
- Rankin, Int J Mol Sci 2020
- Sha, Nutrients 2024
- Shiojima, J Am Nutr Assoc 2022
- Wilkens, JAMA 2010
- Xu, Menopause 2020
- Zadro, Pain Physician 2017
- Zhou, Front Nutr 2022
Join today to unlock all member benefits including
full access to all CL Answers and over 1,400 product reviews.
Join Now
Already a member? Sign In Here.
Join now at www.consumerlab.com/join/
Join over 300,000 people on our weekly email list.
The "Latest Update" date indicates when new information was most recently added to this article. In the full article, the newest information is highlighted in yellow.
|